Sertraline
Who holds supplier records for Sertraline? 6 organisations hold a current record for Sertraline: an active US FDA Type II Drug Master File. A further 3 organisations have only historical (inactive) DMF filings. Recorded organisation countries for current records: India (6).
Most records are filed under another form of this substance: Sertraline Hydrochloride (19 current sources). A DMF or CEP is listed under the form it names.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Sertraline: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/sertraline
Reading the evidence
- 6 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- Most recorded organisations are in India
6 of the 6 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.
- 3 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (6)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Sertraline. Country is the organisation's recorded country, not necessarily the manufacturing site.
- APITORIA PHARMA PRIVATE LTDIndia Company GMP cert on recordActive DMF 22652 · latest filing Mar 2009
- Exemed PharmaceuticalsIndia Company GMP cert on recordActive DMF 40690 · latest filing Oct 2024
- LEE PHARMA LTDIndia Company GMP cert on recordActive DMF 37733 · latest filing Apr 2023
- R L Fine Chem Pvt. Ltd.IndiaActive DMF 40764 · latest filing Oct 2024
- R.L.FINE CHEM PRIVATE LIMITEDIndiaActive DMF 40528 · latest filing Sept 2024
- WANBURY LTDIndiaActive DMF 19931 · latest filing Oct 2006
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Historical records (3)
Organisations whose Type II DMFs for Sertraline are no longer active. These show a past filing, not current supply.
Show all 3 historical records
- Spain · Inactive DMF 25097 · filed Jun 2011
- RANBAXY LABORATORIES LTDInactive DMF 18906 · filed Oct 2005
- Italy · Inactive DMF 16848 · filed Sept 2003
US product patents and exclusivity
The FDA Orange Book lists patents and exclusivities for specific approved products (59 listed products contain Sertraline). The latest listed exclusivity ended 18 Jan 2026. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.
Other forms of this substance
A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:
Overview
Sertraline is a selective serotonin reuptake inhibitor (SSRI) used primarily to treat major depressive disorder, anxiety and certain types of phobia. It functions by increasing the amount of serotonin, a natural substance in the brain that helps maintain mental balance.
Chemical identity
- IUPAC name
- (1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalen-1-amine
- Canonical SMILES
- CN[C@H]1CC[C@H](C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl
- InChIKey
- VGKDLMBJGBXTGI-KRWDZBQOSA-N
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Sertraline?
6 organisations hold an active US FDA Type II Drug Master File or a CEP for Sertraline: APITORIA PHARMA PRIVATE LTD (India), Exemed Pharmaceuticals (India), LEE PHARMA LTD (India), R L Fine Chem Pvt. Ltd. (India), R.L.FINE CHEM PRIVATE LIMITED (India) and WANBURY LTD (India). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Sertraline Drug Master Files are active?
APITORIA PHARMA PRIVATE LTD (DMF 22652), Exemed Pharmaceuticals (DMF 40690), LEE PHARMA LTD (DMF 37733), R L Fine Chem Pvt. Ltd. (DMF 40764), R.L.FINE CHEM PRIVATE LIMITED (DMF 40528) and WANBURY LTD (DMF 19931). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Sertraline records mean?
3 organisations have only inactive Type II DMFs for Sertraline. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
How do I qualify a Sertraline supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Sertraline?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.